Vice President of Clinical Effectiveness, Baylor Scott & White Health
Andrew Masica, MD, MSCI serves as Chief Clinical Effectiveness Officer for Baylor Scott & White Health. Following graduation from Harvard University, Dr. Masica received his MD from the Indiana University School of Medicine, underwent residency training at University of Texas-Southwestern Medical Center, and completed a clinical pharmacology research fellowship and a Master of Clinical Investigation program at the Vanderbilt University School of Medicine.
Since his arrival at Baylor Health Care System in 2006, Dr. Masica has maintained system-level roles in quality, patient safety, and health services research, while continuing to practice clinically as a board certified hospital-based internist. His main research interests are in the areas of rational use of therapeutic drugs, clinical effectiveness, and implementation science. He has received funding as a principal or co-investigator on several studies funded by the Agency for Healthcare Research and Quality or the National Institutes of Health, and has published numerous articles in peer-reviewed journals. Dr. Masica’s operational responsibilities are focused on implementation of evidence-based practices into daily patient care, particularly the design of accelerated adoption strategies and assessing impacts of those implementations.
Dr. Masica has been designated as a Senior Fellow by the Society of Hospital Medicine, and has an appointment as an Assistant Clinical Professor of Medicine at the Texas A&M Health Sciences Center (Dallas Campus). He leads the Baylor Scott & White Health involvement in the High Value Healthcare Collaborative and the Centers for Medicare and Medicaid Services-supported Hospital Engagement Network. Dr. Masica was also recognized by the Dallas-Fort Worth Hospital Council as its 2012 Young Healthcare Executive of the Year.